|
RPP38 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.857590E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.946400E-01 |
| Normal-vs-Stage2 |
3.903000E-01 |
| Normal-vs-Stage3 |
2.436000E-01 |
| Normal-vs-Stage4 |
9.633600E-04 |
| Stage1-vs-Stage2 |
8.040800E-01 |
| Stage1-vs-Stage3 |
6.611400E-01 |
| Stage1-vs-Stage4 |
3.180900E-03 |
| Stage2-vs-Stage3 |
9.516000E-01 |
| Stage2-vs-Stage4 |
4.159700E-02 |
| Stage3-vs-Stage4 |
1.084060E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.318800E-01 |
| Normal-vs-AfricanAmerican |
3.378200E-01 |
| Normal-vs-Asian |
2.309400E-01 |
| Caucasian-vs-AfricanAmerican |
8.875200E-01 |
| Caucasian-vs-Asian |
9.173200E-01 |
| AfricanAmerican-vs-Asian |
9.288600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.348600E-01 |
| Normal-vs-Female |
1.628390E-01 |
| Male-vs-Female |
6.089400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.876000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.072400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.691900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.936420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.770400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.537400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.275600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.351800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.434800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.929200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.579200E-01 |
| Classical-VS-Follicular |
9.409600E-01 |
| Classical-VS-Other |
8.852000E-01 |
| Classical-VS-Normal |
2.088000E-01 |
| Tall-VS-Follicular |
5.018400E-01 |
| Tall-VS-Other |
8.299000E-01 |
| Tall-VS-Normal |
1.238400E-01 |
| Follicular-VS-Other |
9.012400E-01 |
| Follicular-VS-Normal |
3.728200E-01 |
| Other-VS-Normal |
5.198800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.493800E-01 |
| Normal-vs-N1 |
2.995900E-02 |
| N0-vs-N1 |
1.024000E-01 |
|
|
